These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 22734070)

  • 1. L-Leucine improves the anemia and developmental defects associated with Diamond-Blackfan anemia and del(5q) MDS by activating the mTOR pathway.
    Payne EM; Virgilio M; Narla A; Sun H; Levine M; Paw BH; Berliner N; Look AT; Ebert BL; Khanna-Gupta A
    Blood; 2012 Sep; 120(11):2214-24. PubMed ID: 22734070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Activation of the mTOR pathway by the amino acid (L)-leucine in the 5q- syndrome and other ribosomopathies.
    Boultwood J; Yip BH; Vuppusetty C; Pellagatti A; Wainscoat JS
    Adv Biol Regul; 2013 Jan; 53(1):8-17. PubMed ID: 23031788
    [TBL] [Abstract][Full Text] [Related]  

  • 3. L-Leucine improves the anaemia in models of Diamond Blackfan anaemia and the 5q- syndrome in a TP53-independent way.
    Narla A; Payne EM; Abayasekara N; Hurst SN; Raiser DM; Look AT; Berliner N; Ebert BL; Khanna-Gupta A
    Br J Haematol; 2014 Nov; 167(4):524-528. PubMed ID: 25098371
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dietary L-leucine improves the anemia in a mouse model for Diamond-Blackfan anemia.
    Jaako P; Debnath S; Olsson K; Bryder D; Flygare J; Karlsson S
    Blood; 2012 Sep; 120(11):2225-8. PubMed ID: 22791294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of the mTOR signaling pathway by L-leucine in 5q- syndrome and other RPS14-deficient erythroblasts.
    Yip BH; Vuppusetty C; Attwood M; Giagounidis A; Germing U; Lamikanra AA; Roberts DJ; Maciejewski JP; Vandenberghe P; Mecucci C; Wainscoat JS; Pellagatti A; Boultwood J
    Leukemia; 2013 Aug; 27(8):1760-3. PubMed ID: 23337929
    [No Abstract]   [Full Text] [Related]  

  • 6. Haploinsufficiency for ribosomal protein genes causes selective activation of p53 in human erythroid progenitor cells.
    Dutt S; Narla A; Lin K; Mullally A; Abayasekara N; Megerdichian C; Wilson FH; Currie T; Khanna-Gupta A; Berliner N; Kutok JL; Ebert BL
    Blood; 2011 Mar; 117(9):2567-76. PubMed ID: 21068437
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Delayed globin synthesis leads to excess heme and the macrocytic anemia of Diamond Blackfan anemia and del(5q) myelodysplastic syndrome.
    Yang Z; Keel SB; Shimamura A; Liu L; Gerds AT; Li HY; Wood BL; Scott BL; Abkowitz JL
    Sci Transl Med; 2016 May; 8(338):338ra67. PubMed ID: 27169803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transcription factors Fli1 and EKLF in the differentiation of megakaryocytic and erythroid progenitor in 5q- syndrome and in Diamond-Blackfan anemia.
    Neuwirtova R; Fuchs O; Holicka M; Vostry M; Kostecka A; Hajkova H; Jonasova A; Cermak J; Cmejla R; Pospisilova D; Belickova M; Siskova M; Hochova I; Vondrakova J; Sponerova D; Kadlckova E; Novakova L; Brezinova J; Michalova K
    Ann Hematol; 2013 Jan; 92(1):11-8. PubMed ID: 22965552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the DNA damage response in zebrafish and cellular models of Diamond Blackfan anemia.
    Danilova N; Bibikova E; Covey TM; Nathanson D; Dimitrova E; Konto Y; Lindgren A; Glader B; Radu CG; Sakamoto KM; Lin S
    Dis Model Mech; 2014 Jul; 7(7):895-905. PubMed ID: 24812435
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-Diamond Blackfan anemia disorders of ribosome function: Shwachman Diamond syndrome and 5q- syndrome.
    Burwick N; Shimamura A; Liu JM
    Semin Hematol; 2011 Apr; 48(2):136-43. PubMed ID: 21435510
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic deletions in AML and MDS.
    Ebert BL
    Best Pract Res Clin Haematol; 2010 Dec; 23(4):457-61. PubMed ID: 21130407
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defects of protein production in erythroid cells revealed in a zebrafish Diamond-Blackfan anemia model for mutation in RPS19.
    Zhang Y; Ear J; Yang Z; Morimoto K; Zhang B; Lin S
    Cell Death Dis; 2014 Jul; 5(7):e1352. PubMed ID: 25058426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ribosomal protein deficiency causes Tp53-independent erythropoiesis failure in zebrafish.
    Yadav GV; Chakraborty A; Uechi T; Kenmochi N
    Int J Biochem Cell Biol; 2014 Apr; 49():1-7. PubMed ID: 24417973
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rps14, Csnk1a1 and miRNA145/miRNA146a deficiency cooperate in the clinical phenotype and activation of the innate immune system in the 5q- syndrome.
    Ribezzo F; Snoeren IAM; Ziegler S; Stoelben J; Olofsen PA; Henic A; Ferreira MV; Chen S; Stalmann USA; Buesche G; Hoogenboezem RM; Kramann R; Platzbecker U; Raaijmakers MHGP; Ebert BL; Schneider RK
    Leukemia; 2019 Jul; 33(7):1759-1772. PubMed ID: 30651631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Haploinsufficiency of RPS14 in 5q- syndrome is associated with deregulation of ribosomal- and translation-related genes.
    Pellagatti A; Hellström-Lindberg E; Giagounidis A; Perry J; Malcovati L; Della Porta MG; Jädersten M; Killick S; Fidler C; Cazzola M; Wainscoat JS; Boultwood J
    Br J Haematol; 2008 Jul; 142(1):57-64. PubMed ID: 18477045
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Deficiency of ribosomal protein S19 during early embryogenesis leads to reduction of erythrocytes in a zebrafish model of Diamond-Blackfan anemia.
    Uechi T; Nakajima Y; Chakraborty A; Torihara H; Higa S; Kenmochi N
    Hum Mol Genet; 2008 Oct; 17(20):3204-11. PubMed ID: 18653748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deletion 5q MDS: molecular and therapeutic implications.
    Komrokji RS; Padron E; Ebert BL; List AF
    Best Pract Res Clin Haematol; 2013 Dec; 26(4):365-75. PubMed ID: 24507813
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ribosomal protein S19 deficiency leads to reduced proliferation and increased apoptosis but does not affect terminal erythroid differentiation in a cell line model of Diamond-Blackfan anemia.
    Miyake K; Utsugisawa T; Flygare J; Kiefer T; Hamaguchi I; Richter J; Karlsson S
    Stem Cells; 2008 Feb; 26(2):323-9. PubMed ID: 17962699
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired ribosomopathies in leukemia and solid tumors.
    Vlachos A
    Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):716-719. PubMed ID: 29222326
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High level of full-length cereblon mRNA in lower risk myelodysplastic syndrome with isolated 5q deletion is implicated in the efficacy of lenalidomide.
    Jonasova A; Bokorova R; Polak J; Vostry M; Kostecka A; Hajkova H; Neuwirtova R; Siskova M; Sponerova D; Cermak J; Mikulenkova D; Cervinek L; Brezinova J; Michalova K; Fuchs O
    Eur J Haematol; 2015 Jul; 95(1):27-34. PubMed ID: 25284710
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.